Page last updated: 2024-12-11
mono(3,5-dibromosalicyl)fumarate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
mono(3,5-dibromosalicyl)fumarate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6438567 |
SCHEMBL ID | 87888 |
SCHEMBL ID | 9475517 |
MeSH ID | M0164649 |
Synonyms (11)
Synonym |
---|
mono(3,5-dibromosalicyl)fumarate |
2-butenedioic acid (e)-, mono((3,5-dibromo-2-hydroxyphenyl)methyl) ester |
93705-06-7 |
3,5-dbsf |
fmda-3,5 |
fumaryl monodibromoaspirin |
(e)-4-[(3,5-dibromo-2-hydroxyphenyl)methoxy]-4-oxobut-2-enoic acid |
SCHEMBL87888 |
SCHEMBL9475517 |
(e)-4-((3,5-dibromo-2-hydroxybenzyl)oxy)-4-oxobut-2-enoic acid |
STARBLD0031810 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.09
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.09) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |